Long Healthcare and BiotechI think we will go for all time highs soon
TP 1 over 900
Got 2 stop losses on chart depending on time horizon and risk apatite
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11 CHF
9.62 B CHF
40.91 B CHF
849.66 M
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
FIGI
BBG00JHW5BX3
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related stocks
Eli Lilly (LLY) – Full Technical + Fundamental Analysis (July 20
I wanted to take a deeper dive into LLY and analyze more than just trendlines—looking into both the technical structure and the broader fundamentals of the stock.
Sources: i have a list of sources at the end of my report
Technical Breakdown:
Current Price: ~$771.75
Resistance Zone: $950–970 p
$LLY Technical Setup – Breakout ReloadingNYSE:LLY is holding a critical mid-range level, and the chart hints at a potential accumulation before a breakout. Here's the updated view:
🔹 Horizontal Range Still Intact: Price remains trapped between ~$710 support and ~$965 resistance. These levels have acted as major turning points for over a
$LLY Low Risk - CookieLow Risk opportunity on NYSE:LLY it is right at the wholesale level... good holding area.. Have a beautiful day!
ELI LILLY Is starting its next big rally.Eli Lilly (LLY) is about to test its 1W MA50 (blue trend-line) following a rebound just below the 1W MA100 (green trend-line). The latter, has been the ultimate market Support since May 2018 (last time it broke below it).
The overall correction since the July 15 2024 High seems like a Bull Flag pat
Eli Lillly $LLYNYSE:LLY – Long Setup Ahead of June FOMC
Eli Lilly remains fundamentally strong, with robust growth in revenue (+45% YoY), driven by weight-loss and diabetes drugs like Mounjaro and Zepbound. Despite this, the stock saw a recent pullback after a lowered FY25 profit outlook.
Technical View:
LLY is
LLY Daily: Navigating Key Levels - Two Strategic OpportunitiesOVERVIEW:
LLY has recently undergone a significant correction from its highs, finding strong demand at a crucial support zone. Price action now presents two distinct, high-probability long entry scenarios based on the stock's interaction with key horizontal levels. My analysis outlines potential ent
LLY is now interested?Interested Chart??
Eli Lilly (LLY) is one of the Big Pharma stocks with strong fundamentals, and it's a growth stock too. So, is it a good time to accumulate now??
After LLY's price kept dropping for a while, it now seems to be forming a structure where it's not falling below $700. Looks like it
LLY: Potential Bounce Play with 20–30% UpsideLooking for a stock that had strong momentum before but has slowed down over the past year? One that’s now trading near the bottom of its consolidation range, with about a 30% drop from recent highs? LLY fits that description pretty well.
Based on its pattern, it looks like there’s a good chance it
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
ELI LILLY 21/43Yield to maturity
7.89%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50Yield to maturity
7.41%
Maturity date
May 15, 2050
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.31%
Maturity date
Sep 15, 2060
US532457BU1
ELI LILLY 19/59Yield to maturity
6.29%
Maturity date
Mar 15, 2059
LLYH
ELI LILLY 17/47Yield to maturity
6.25%
Maturity date
May 15, 2047
US532457BT4
ELI LILLY 19/49Yield to maturity
6.25%
Maturity date
Mar 15, 2049
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.22%
Maturity date
Mar 1, 2045
US532457BS6
ELI LILLY 19/39Yield to maturity
6.17%
Maturity date
Mar 15, 2039
US532457CG1
ELI LILLY 23/53Yield to maturity
6.00%
Maturity date
Feb 27, 2053
US532457CH9
ELI LILLY 23/63Yield to maturity
6.00%
Maturity date
Feb 27, 2063
US532457CN6
ELI LILLY 24/64Yield to maturity
5.98%
Maturity date
Feb 9, 2064
See all 0Q1G bonds
Curated watchlists where 0Q1G is featured.
Frequently Asked Questions
The current price of 0Q1G is 540 CHF — it has increased by 120.45% in the past 24 hours. Watch ELI LILLY AND COMPANY COM NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ELI LILLY AND COMPANY COM NPV stocks are traded under the ticker 0Q1G.
We've gathered analysts' opinions on ELI LILLY AND COMPANY COM NPV future price: according to them, 0Q1G price has a max estimate of 955.45 CHF and a min estimate of 541.96 CHF. Watch 0Q1G chart and read a more detailed ELI LILLY AND COMPANY COM NPV stock forecast: see what analysts think of ELI LILLY AND COMPANY COM NPV and suggest that you do with its stocks.
0Q1G reached its all-time high on Nov 27, 2023 with the price of 540 CHF, and its all-time low was 70 CHF and was reached on Feb 7, 2018. View more price dynamics on 0Q1G chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0Q1G stock is 54.64% volatile and has beta coefficient of 0.77. Track ELI LILLY AND COMPANY COM NPV stock price on the chart and check out the list of the most volatile stocks — is ELI LILLY AND COMPANY COM NPV there?
Today ELI LILLY AND COMPANY COM NPV has the market capitalization of 587.25 B, it has increased by 0.47% over the last week.
Yes, you can track ELI LILLY AND COMPANY COM NPV financials in yearly and quarterly reports right on TradingView.
ELI LILLY AND COMPANY COM NPV is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
0Q1G earnings for the last quarter are 2.96 CHF per share, whereas the estimation was 2.88 CHF resulting in a 2.51% surprise. The estimated earnings for the next quarter are 4.39 CHF per share. See more details about ELI LILLY AND COMPANY COM NPV earnings.
ELI LILLY AND COMPANY COM NPV revenue for the last quarter amounts to 11.27 B CHF, despite the estimated figure of 11.21 B CHF. In the next quarter, revenue is expected to reach 11.55 B CHF.
0Q1G net income for the last quarter is 2.44 B CHF, while the quarter before that showed 4.00 B CHF of net income which accounts for −39.01% change. Track more ELI LILLY AND COMPANY COM NPV financial stats to get the full picture.
Yes, 0Q1G dividends are paid quarterly. The last dividend per share was 1.26 CHF. As of today, Dividend Yield (TTM)% is 0.73%. Tracking ELI LILLY AND COMPANY COM NPV dividends might help you take more informed decisions.
ELI LILLY AND COMPANY COM NPV dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 16, 2025, the company has 47 K employees. See our rating of the largest employees — is ELI LILLY AND COMPANY COM NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELI LILLY AND COMPANY COM NPV EBITDA is 19.08 B CHF, and current EBITDA margin is 41.75%. See more stats in ELI LILLY AND COMPANY COM NPV financial statements.
Like other stocks, 0Q1G shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELI LILLY AND COMPANY COM NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELI LILLY AND COMPANY COM NPV technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELI LILLY AND COMPANY COM NPV stock shows the strong buy signal. See more of ELI LILLY AND COMPANY COM NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.